EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Association of Blood Lipid Markers and 20-year Cardiovascular Disease Incidence: The ATTICA Epidemiological Cohort Study (2002–2022)

Styliani Lagou, Fotios Barkas, Sofia-Panagiota Giannakopoulou, Amalia-Despoina Koutsogianni, Petros Spyridonas Adamidis, Georgia Anastasiou, Konstantina Kyrili, Christina Chrysohoou, Costas Tsioufis, Christos Pitsavos, Petros P. Sfikakis, Demosthenes Panagiotakos und 1 weitere

Journal of Atherosclerosis Prevention and Treatment · 2025

DOI: 10.4103/aptj.aptj_4_25 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Atherosclerosis Prevention and Treatment, 2025. Verfasst von Styliani Lagou und 12 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The association of blood lipids and apolipoproteins with cardiovascular disease (CVD) is well established. However, there are ongoing discussions on which lipid biomarker could better predict CVD risk in the long term.

Aim

To investigate the association of blood lipid profile biomarkers with 20-year incidence of CVD. Materials and Methods: The ATTICA study is a population-based cohort study investigating CVD incidence and relevant risk factors, including lipids, in 3042 primary prevention population of the metropolitan region of Athens. In 2022, the 20-year follow-up was performed in 2169 individuals who agreed to participate. Analyses were adjusted for gender, age, body mass index, smoking, physical activity, adherence to Mediterranean diet, family CVD history, hypertension, diabetes, and lipid-lowering medication at baseline.

Results

In total, information from 1988 individuals was analyzed in 20-year follow-up (50% men, 37% family CVD history, 31% hypertension, 7% diabetes, 55% current/past smoking, 18% obesity, 43% hypercholesterolemia, and 12% on lipid-lowering drugs at baseline). During the follow-up, 718 (36.1%) individuals experienced a first CVD event. Total cholesterol, low-density lipoprotein cholesterol (LDL-C), non-high-density-lipoprotein cholesterol (non-HDL-C), and apolipoprotein B were independent predictors of CVD. Among lipid indices, non-HDL-C and LDL-C demonstrated the best correct reclassification ability (continuous Net Reclassification Improvement = 38.4% and 38.0%, respectively).

Conclusions

Non-HDL-C has a similar ability with LDL-C to predict and reclassify 20-year CVD incidence in a middle-aged, apparently healthy population.

Zitieren

APA

Lagou, S., Barkas, F., Giannakopoulou, S., Koutsogianni, A., Adamidis, P. S., Anastasiou, G., Kyrili, K., Chrysohoou, C., Tsioufis, C., Pitsavos, C., Sfikakis, P. P., Panagiotakos, D., & Liberopoulos, E. (2025). Association of Blood Lipid Markers and 20-year Cardiovascular Disease Incidence: The ATTICA Epidemiological Cohort Study (2002–2022). Journal of Atherosclerosis Prevention and Treatment. https://doi.org/10.4103/aptj.aptj_4_25

Vancouver

Lagou S, Barkas F, Giannakopoulou S, Koutsogianni A, Adamidis PS, Anastasiou G, et al. Association of Blood Lipid Markers and 20-year Cardiovascular Disease Incidence: The ATTICA Epidemiological Cohort Study (2002–2022). Journal of Atherosclerosis Prevention and Treatment. 2025. doi:10.4103/aptj.aptj_4_25

BibTeX
@article{Lagou2025,
  author = {Lagou, Styliani and Barkas, Fotios and Giannakopoulou, Sofia-Panagiota and Koutsogianni, Amalia-Despoina and Adamidis, Petros Spyridonas and Anastasiou, Georgia and Kyrili, Konstantina and Chrysohoou, Christina and Tsioufis, Costas and Pitsavos, Christos and Sfikakis, Petros P. and Panagiotakos, Demosthenes and Liberopoulos, Evangelos},
  title = {Association of Blood Lipid Markers and 20-year Cardiovascular Disease Incidence: The ATTICA Epidemiological Cohort Study (2002–2022)},
  journal = {Journal of Atherosclerosis Prevention and Treatment},
  year = {2025},
  doi = {10.4103/aptj.aptj_4_25}
}
Kostenlos starten →